Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

by Armstrong, Matthew J., Hull, Diana, Guo, Kathy, Barton, Darren, Hazlehurst, Jonathan M., Gathercole, Laura L., Nasiri, Maryam, Yu, Jinglei, Gough, Stephen C., Newsome, Philip N., Tomlinson, Jeremy W.
Published 2016

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

by Armstrong, Matthew J, Barton, Darren, Gaunt, Piers, Hull, Diana, Guo, Kathy, Stocken, Deborah, Gough, Stephen C L, Tomlinson, Jeremy W, Brown, Rachel M, Hübscher, Stefan G, Newsome, Philip N
Published 2013

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

by Armstrong, Matthew James, Gaunt, Piers, Aithal, Guruprasad P., Barton, Darren, Hull, Diana, Parker, Richard, Hazlehurst, Jonathan M., Guo, Kathy, Abouda, George, Aldersley, Mark A., Stocken, Deborah, Gough, Stephen C., Tomlinson, Jeremy W., Brown, Rachel M., Hübscher, Stefan G., Newsome, Philip N.
Published 2015